Search Grant Opportunities

Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

ID: PAR-23-169 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The purpose of this reissued Funding Opportunity Announcement (FOA) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.

Overview

Category of Funding
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 4/20/23 the National Institutes of Health posted grant opportunity PAR-23-169 for Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.855 Allergy and Infectious Diseases Research.

Timing

Posted Date
April 20, 2023, 12:00 a.m. EDT
Closing Date
May 23, 2025, 12:00 a.m. EDT Past Due
Last Updated
May 15, 2025, 3:27 p.m. EDT
Version
2
Archive Date
June 22, 2025

Eligibility

Eligible Applicants
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Special district governments
Independent school districts
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
City or township governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Small businesses
Native American tribal governments (Federally recognized)
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$350,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-23-169.html

Documents

Posted documents for PAR-23-169

Grant Awards

Grants awarded through PAR-23-169

Incumbent or Similar Grants

Grants similar to PAR-23-169

Similar Active Opportunities

Open grant opportunities similar to PAR-23-169

Experts for Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire